
Therapeutic Area | MeSH |
|---|---|
| cardiovascular diseases | D002318 |
| signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| KAPSPARGO SPRINKLE | Sun Pharmaceuticals | N-210428 RX | 2018-01-26 | 4 products, RLD, RS |
| TOPROL-XL | Toprol Acquisition | N-019962 RX | 1992-01-10 | 4 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DUTOPROL | Concordia Laboratories | N-021956 DISCN | 2006-08-28 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LOPRESSOR | Rubicon Research | N-219373 RX | 2025-04-10 | 1 products, RLD, RS |
| LOPRESSOR | Validus Pharmaceuticals | N-017963 RX | 1982-01-01 | 2 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LOPRESSOR HCT | Validus Pharmaceuticals | N-018303 RX | 1984-12-31 | 1 products, RLD |
Brand Name | Status | Last Update |
|---|---|---|
| hypertensolol | unapproved drug other | 2011-08-01 |
| kapspargo | New Drug Application | 2023-04-12 |
| lopressor | New Drug Application | 2025-09-05 |
| lopressor hct | New Drug Application | 2023-09-13 |
| metoprolol | ANDA | 2025-01-15 |
| metoprolol succinate | ANDA | 2025-09-30 |
| metoprolol succinate er | ANDA | 2024-04-11 |
| metoprolol succinate metoprolol succinate er | ANDA | 2024-01-10 |
| metoprolol succinate metoprolol tartrate | ANDA | 2024-01-09 |
| metoprolol tartate | ANDA | 2015-04-01 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
| Drug common name | Metoprolol |
| INN | metoprolol |
| Description | Metoprolol is a propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1. It has a role as a beta-adrenergic antagonist, an antihypertensive agent, a xenobiotic, an environmental contaminant and a geroprotector. It is a propanolamine, an aromatic ether, a secondary alcohol and a secondary amino compound. |
| Classification | Small molecule |
| Drug class | beta-blockers (propranolol type) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | COCCc1ccc(OCC(O)CNC(C)C)cc1 |
| PDB | — |
| CAS-ID | 37350-58-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL13 |
| ChEBI ID | 6904 |
| PubChem CID | 4171 |
| DrugBank | DB00264 |
| UNII ID | GEB06NHM23 (ChemIDplus, GSRS) |











